Introduction It has been estimated that one out of every four women experience first‐
trimester miscarriage. Missed miscarriage is a common form of early miscarriage where the …

Background The anti-progesterone drug mifepristone and the prostaglandin misoprostol can
be used to treat missed miscarriage. However, it is unclear whether a combination of …

Objective To assess the cost‐effectiveness of mifepristone and misoprostol (MifeMiso)
compared with misoprostol only for the medical management of a missed miscarriage …

Trial design A randomised, parallel-group, double-blind, placebo-controlled multicentre
study with health economic and nested qualitative studies to determine if mifepristone …

Objectives To evaluate the efficacy of combined mifepristone and misoprostol compared to
misoprostol alone in outpatient medical treatment of first trimester miscarriage. Additionally …

Background First trimester miscarriage affects 20% of pregnancies. Medical management
has a high degree of patient acceptance and does not increase the risk of infection …

This prospective study of 104 women investigated the dose-related efficacy of mifepristone
combined with oral misoprostol in the management of first trimester miscarriage (missed …

Objective To investigate whether letrozole pre‐treatment is non‐inferior to mifepristone pre‐
treatment, followed by misoprostol, for complete evacuation in the medical treatment of first …

Introduction Medical treatment is a less invasive alternative to surgical management of
missed miscarriage. Studies have shown that pretreatment with mifepristone can increase …

BACKGROUND: This study aims to assess the efficacy of a combination of mifepristone and
misoprostol in the management of missed miscarriage and anembryonic pregnancy …